Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−437,868−100.0%Sold outHolders
Q1 2026437,868$17.6M<0.1%+211,892+93.8%AddedHolders
Q4 2025225,976$5.68M<0.1%+42,960+23.5%AddedHolders
Q3 2025183,016$4.14M<0.1%+16,881+10.2%AddedHolders
Q2 2025166,135$2.88M<0.1%−475,262−74.1%ReducedHolders
Q1 2025641,397$14.0M<0.1%+37,741+6.3%AddedHolders
Q4 2024603,656$19.3M<0.1%−457−0.1%ReducedHolders
Q3 2024604,113$17.4M<0.1%−498,720−45.2%ReducedHolders
Q2 20241,102,833$42.3M<0.1%+340,718+44.7%AddedHolders
Q1 2024762,115$44.8M<0.1%+243,278+46.9%AddedHolders
Q4 2023518,837$31.1M<0.1%−21,839−4.0%ReducedHolders
Q3 2023540,676$20.6M<0.1%−611,720−53.1%ReducedHolders
Q2 20231,152,396$105.0M<0.1%+111,415+10.7%AddedHolders
Q1 20231,040,981$68.7M<0.1%+540,194+107.9%AddedHolders
Q4 2022500,787$25.9M<0.1%−102,466−17.0%ReducedHolders
Q3 2022603,253$41.2M<0.1%+429,625+247.4%AddedHolders
Q2 2022173,628$7.85M<0.1%+40,445+30.4%AddedHolders
Q1 2022133,183$6.77M<0.1%+84,634+174.3%AddedHolders
Q4 202148,549$2.29M<0.1%−6,189−11.3%ReducedHolders
Q3 202154,738$1.80M<0.1%−542,178−90.8%ReducedHolders
Q2 2021596,916$37.7M<0.1%+56,809+10.5%AddedHolders
Q1 2021540,107$23.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.